| Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
|---|
| 04/03/2002 | EP1193252A2 Beta-Lactams useful for preparation of substituted isoserine esters using metal alkoxides |
| 04/03/2002 | EP1192166A1 Group(vii) transition-metal complexes with multidentate aminopolycarboxylate ligands and a kit for producing them |
| 04/03/2002 | EP1192125A2 Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
| 04/03/2002 | EP1192119A2 Process for the preparation of 3,3-dimethylbutanal |
| 04/03/2002 | EP0874645B1 Perfluoroalkyl-containing metal complexes and their use in nmr diagnostics |
| 04/03/2002 | EP0770593B1 Tris(3-aminopropyl)amine derivative and detergent composition containing the same |
| 04/03/2002 | EP0716600B1 Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
| 04/03/2002 | CN1343219A Substituted phenethylamine derivatives |
| 04/03/2002 | CN1342652A Spirocyclophophorous amine |
| 04/03/2002 | CN1342642A Process for synthesizing N-2-aroylphenyl-tyrosine |
| 04/02/2002 | US6365770 Production of alkyl 6-aminocaproate |
| 04/02/2002 | US6365754 Process for producing erythro-3-amino-2-hydroxybutyric acid derivatives |
| 04/02/2002 | US6365750 Methods for the preparation of taxanes using oxazolidine intermediates |
| 04/02/2002 | US6365732 Process for obtaining stereoisomers from biomass |
| 04/02/2002 | US6365611 Pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same |
| 04/02/2002 | CA2074486C Process for producing aminocarboxylic acid salt |
| 03/28/2002 | WO2002024715A2 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 03/28/2002 | WO2002024629A1 Zwitterionic tachykinin receptor antagonists |
| 03/28/2002 | WO2002024628A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE β-AMINO ACID DERIVATIVE |
| 03/28/2002 | WO2002024613A2 Resorcinol derivatives |
| 03/28/2002 | WO2002024330A2 Amino acid complexes and the use thereof in producing olefin polymers |
| 03/28/2002 | US20020038051 As catalyst for dehydrogenating alcohols |
| 03/28/2002 | US20020038050 Process for the manufacture of amino carboxylic acids |
| 03/28/2002 | US20020037998 For therapy of hepatitis C virus (HCV) infection |
| 03/28/2002 | US20020037909 Enamine derivatives |
| 03/28/2002 | CA2423356A1 Zwitterionic tachykinin receptor antagonists |
| 03/28/2002 | CA2423262A1 Resorcinol derivatives |
| 03/27/2002 | EP1191033A2 Compositions and methods for protein structural determinations |
| 03/27/2002 | EP1189881A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 03/27/2002 | EP1189874A1 Excitatory amino acid receptor modulators |
| 03/27/2002 | EP1189873A1 Excitatory amino acid receptor modulators |
| 03/27/2002 | EP0920410B1 Preparation of cyclohexene carboxylate derivatives |
| 03/27/2002 | EP0865421B1 Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors |
| 03/27/2002 | EP0820430B1 Reductive process for the preparation of ethylenediaminedisuccinic acid |
| 03/27/2002 | EP0766670B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 03/26/2002 | CA2260330C Process for the preparation of aqueous solutions of betaine |
| 03/26/2002 | CA2032498C Novel 8-substituted-2-aminotetralines |
| 03/21/2002 | WO2002022626A1 Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds |
| 03/21/2002 | WO2002022622A2 Synthesis of 2-hydroxymethylglutamic acid and congeners thereof |
| 03/21/2002 | WO2002022562A1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | WO2002022561A1 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | WO2002022559A2 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | WO2002022558A2 2-amino-2-alkyl-3 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | WO2002022557A2 2-amino-2-alkyl-4 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | WO2002022553A2 Non-natural basic amino acids, their preparation and use |
| 03/21/2002 | WO2002022549A1 Process for the removal of nitrobenzenesulfonyl |
| 03/21/2002 | WO2001072689A3 Method for separating a basic amino acid from fermentation broth |
| 03/21/2002 | WO2001068729A8 Compositions and methods for selectively binding amines or amino acid enantiomers over their counter-enantiomers |
| 03/21/2002 | US20020035283 Using hydrogenation catalyst complex containing ruthenium |
| 03/21/2002 | US20020035269 Method for separating a basic amino acid from fermentation broth |
| 03/21/2002 | US20020033184 Method and kit for removing aldehyde-based stains |
| 03/21/2002 | CA2459599A1 Non-natural basic amino acids, their preparation and use |
| 03/21/2002 | CA2421279A1 2-amino-2-alkyl-3 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | CA2420529A1 2-amino-2-alkyl-4 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | CA2420450A1 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | CA2420007A1 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/20/2002 | EP1188741A1 Diammonium ruthenium diethylenetriaminepentaacetate or hydrates thereof and process for the preparation of both |
| 03/20/2002 | EP1187805A1 Process for preparing r-(-)-carnitine from s-(-)-chlorosuccinic acid or from a derivative thereof |
| 03/20/2002 | EP0942913A4 Ethylenediaminetriacetic acid and n-acyl ethylenediaminetriacetic acid silver chelactants |
| 03/20/2002 | EP0915828B1 A process for the production of crystalline aspartic acid |
| 03/20/2002 | CN1340498A Process for preparing glycine |
| 03/19/2002 | US6359169 GABA and L-glutamic acid analogs for antiseizure treatment |
| 03/19/2002 | US6359113 Using fused ring system containing at least 4 aromatic rings, and group containing at least one carbon atom which is capable of bonding to a group to be protected; synthesis, separation |
| 03/19/2002 | US6358922 Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides |
| 03/19/2002 | US6358504 Compounds and compositions for delivering active agents |
| 03/19/2002 | CA2136517C Process for preparing polyimides or their biodegradable polypeptidic hydrolysates |
| 03/14/2002 | WO2001070668B1 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 03/14/2002 | WO2001051919A9 High-throughput formation, identification, and analysis of diverse solid-forms |
| 03/14/2002 | WO2001032130A3 Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
| 03/14/2002 | US20020032343 Process for preparing a complex of a ligand, metal and base |
| 03/13/2002 | EP1185498A2 Synthesis of optically active cyclohexylphenylglycolic acid and its esters |
| 03/13/2002 | EP1185493A1 Quinones for treatment of diseases |
| 03/13/2002 | EP0828704B1 Methods of making (s)-3-(aminomethyl)-5-methylhexanoic acid |
| 03/13/2002 | CN1340043A Phenylalaninol derivatives |
| 03/13/2002 | CN1339431A Process for preparing DL-serine |
| 03/13/2002 | CN1080758C Chelating agent and detergent comprising same |
| 03/12/2002 | US6355807 Multistep process including cyanomethylation, reduction, cyclization, deprotection, oxidation, olefination and amidation |
| 03/12/2002 | US6355806 Regulators of cell proliferation and differentiation, agents for treating skin-related diseases |
| 03/12/2002 | US6355713 β-ketoesters for use as polymer stabilizers |
| 03/12/2002 | US6355683 Fc receptor modulators and uses thereof |
| 03/12/2002 | US6355680 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
| 03/12/2002 | US6355432 Collection of plurality of beads which have binding polymers of different target specific sequence attached thereto; said beads being coded with encoding system whereby target specific sequence of polymer attached to beads can be identified |
| 03/07/2002 | WO2002018361A2 Compounds having activity as inhibitors of cytochrome p450rai |
| 03/07/2002 | WO2002018319A1 Process for making n-aryl-anthranilic acids and their derivatives |
| 03/07/2002 | WO2001089457A3 Thrombopoietin mimetics |
| 03/07/2002 | US20020028250 Carbon-substituted diketopiperazine delivery systems |
| 03/07/2002 | CA2420869A1 Compounds having activity as inhibitors of cytochrome p450rai |
| 03/07/2002 | CA2420003A1 Process for making n-aryl-anthranilic acids and their derivatives |
| 03/06/2002 | EP1183228A2 Esters of l-carnitine or alkanoyl l-carnitines |
| 03/06/2002 | EP1183019A2 Ace-2 inhibiting compounds and methods of use thereof |
| 03/06/2002 | CN1339023A Improved process for preparation of non-hydroscopic salts of L(-)-Carnitine |
| 03/06/2002 | CN1338252A UV adsorbent for forming fatty body |
| 03/05/2002 | US6353025 Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same |
| 03/05/2002 | US6352839 Preparing virginiamycins from an engineered microorganisms, having the ability to prevent biosynthesis of the precursor antibiotic; the microorganism is cultured in the presence of a second precursor and the streptogramin analog is recovered |
| 02/28/2002 | WO2002016403A1 Method of continuously degrading protein |
| 02/28/2002 | WO2001023354A3 Trifluoromethyl-substituted spirocyclic ketoenols and use thereof as pesticides and herbicides |
| 02/28/2002 | US20020026081 Process for producing alpha-aminoketone derivatives |
| 02/28/2002 | US20020026076 Heating the acylamino acid to a temperature in the range from 110 degrees C. to 220 degrees C. and hydrolyzing |
| 02/28/2002 | US20020026069 Reacting L-DOPA with ethanol with thionyl chloride or acid catalyst; devolatilization; water dilution; cosolvent; base precipitation; drying; recrystallizaiton in solvent with antioxidant |
| 02/28/2002 | US20020025949 Anti-epileptogenic agents |